放射線手術和放射線治療機器人市場規模、佔有率和成長分析：按產品組件、基礎技術、臨床應用領域、醫療保健終端用戶和地區分類－2026-2033年產業預測

2024 年全球放射線手術和放射線治療機器人市場價值為 58.4 億美元，預計到 2025 年將成長至 63.3 億美元，到 2033 年將成長至 120.7 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

全球放射線手術和放射線治療機器人市場正蓬勃發展，先進的機器人系統能夠精準地將輻射劑量輸送到腫瘤部位，同時保護周圍健康組織。這項創新縮短了治療時間，並最大限度地減少了癌症患者的副作用。市場正從傳統的固定系統轉向先進的影像引導解決方案和全自動機器人，從而改善治療效果。監管機構對自適應放射治療的支持是成長要素，它不僅鞏固了機器人技術的臨床優勢，還有助於擴大保險覆蓋範圍。採用瓦里安Edge和醫科達Unity等系統的醫院，其患者處理能力顯著提升，並能夠治療以往難以治療的區域，例如移動性腫瘤。效率的提高推動了收入成長，並促使人們進一步投資和研發人工智慧驅動的規劃工具，尤其是在新興市場，從而拓展了全球機器人放射治療的應用領域。

全球放射線手術和放射線治療治療機器人市場的成長要素

隨著人們對微創癌症治療的興趣日益濃厚，以亞毫米級精度著稱的機器人放射外科手術平台的需求也顯著成長。這種高精度可最大限度地減少對周圍組織的二次損傷，並縮短患者的復原時間。醫療專業人員認知到，這種精確度對於有效治療形狀複雜的腫瘤至關重要，因此，在尋求拓展治療方案的過程中，醫院的採購決策也因此受到影響。正因如此，醫療機構紛紛投資於這些先進系統，推動市場成長，並促使製造商加速產品創新，同時提升其作為領先醫療服務提供者的聲譽。

全球放射線手術和放射線治療機器人市場面臨的限制因素

先進放射外科機器人所需的大量前期投資是全球放射線手術和放射線治療機器人市場發展的主要障礙。醫療機構面臨硬體、安裝和專業培訓方面的巨額成本，這些成本往往被視為沉重的財務負擔。預算緊張的機構需要仔細評估成本效益，並且通常會推遲採購，直到確定可靠的報銷方案。這種財務上的猶豫會減緩市場成長，尤其是在公共資金有限的地區。因此，高昂的資本需求阻礙了新型機器人系統在臨床環境中的快速普及。

放射線手術和放射線治療機器人市場的全球趨勢

全球放射線手術和放射線治療機器人市場正日益融合人工智慧 (AI) 技術，徹底革新治療計畫流程。影像分析、自動勾畫輪廓和預測劑量最佳化等方面的創新正在簡化臨床工作流程，顯著縮短計劃時間，同時提高腫瘤靶向的精確度。臨床醫生可以利用基於演算法的洞察，輕鬆實施個人化治療方案，而無需耗費大量資源。這項變革不僅擴大了先進癌症治療的覆蓋範圍，也提高了患者滿意度和臨床成功率。隨著醫療機構採用這些技術，預計市場將顯著成長，從而顯著提升腫瘤治療領域的效率和患者照護。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球放射線手術和放射線治療機器人市場規模：按組件分類

• 機器人系統
  • 機器人放射治療系統
  • 機器人放射外科系統
• 軟體解決方案
• 3D定位監視錄影機
• 技術服務

全球放射線手術和放射線治療機器人市場規模：依底層技術分類

• 直線加速器
• 立體定位放射治療系統
• 粒子束治療系統

全球放射線手術和放射線治療機器人市場規模：按臨床應用分類

• 攝護腺癌
• 腦腫瘤
• 肺癌
• 脊髓病變
• 肝臟病變
• 其他

全球放射線手術和放射線治療機器人市場規模：按醫療領域最終用戶分類

• 醫院
• 門診手術中心
• 癌症專科診所
• 學術研究機構

全球放射線手術和放射線治療機器人市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Siemens Healthineers AG
• Elekta AB
• Accuray Incorporated
• Brainlab AG
• Panacea Medical Technologies Pvt. Ltd.
• IBA Proton Therapy
• Mevion Medical Systems Inc.
• Hitachi Ltd.
• Sumitomo Heavy Industries Ltd.
• ProTom International Inc.
• Optivus Proton Therapy Inc.
• RaySearch Laboratories AB
• DosiSoft SA
• ScandiDos AB
• Vision RT Ltd.
• CIVCO Radiotherapy
• LAP GmbH Laser Applikationen
• Linatech Inc.
• Best Medical International Inc.
• Advanced Oncotherapy plc

結論與建議

Global Radiosurgery And Radiotherapy Robotics Market size was valued at USD 5.84 Billion in 2024 and is poised to grow from USD 6.33 Billion in 2025 to USD 12.07 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global radiosurgery and radiotherapy robotics market is evolving with advanced robotic systems that deliver high-precision radiation doses to tumors while safeguarding surrounding healthy tissue. This innovation leads to shorter treatment durations and minimizes toxicity for cancer patients. The market has shifted from traditional static systems to sophisticated imaging-guided solutions and fully automated robots, enhancing treatment effectiveness. Regulatory support for adaptive radiotherapy is a pivotal growth driver, affirming the clinical benefits of robotic technology and facilitating reimbursement opportunities. Hospitals implementing systems like Varian's Edge and Elekta's Unity experience higher patient throughput and expand into previously challenging treatment areas, such as mobile tumors. This increased efficiency generates higher revenues, fostering further investments and research into AI-enabled planning tools, particularly in emerging markets, expanding the global robotics-enabled radiotherapy landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiosurgery And Radiotherapy Robotics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiosurgery And Radiotherapy Robotics Market Segments Analysis

Global radiosurgery and radiotherapy robotics market is segmented by offering component, underlying technology, clinical application focus, healthcare end user and region. Based on offering component, the market is segmented into Robotic Systems, Software Solutions, 3D Position Monitoring Cameras and Technical Services. Based on underlying technology, the market is segmented into Linear Accelerators, Stereotactic Radiation Systems and Particle Therapy Systems. Based on clinical application focus, the market is segmented into Prostate Cancer, Brain Tumors, Lung Cancer, Spinal Lesions, Liver Lesions and Others. Based on healthcare end user, the market is segmented into Hospitals, Ambulatory Surgery Centers, Specialty Cancer Clinics and Academic Research Institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Radiosurgery And Radiotherapy Robotics Market

The increasing emphasis on minimally invasive oncology is significantly driving the demand for robotic radiosurgery platforms known for their ability to administer treatment with sub-millimeter accuracy. This precision minimizes collateral damage to surrounding tissues and leads to quicker recovery times for patients. Healthcare professionals recognize this accuracy as vital for effectively addressing complex tumor shapes, which in turn influences hospitals' procurement decisions as they strive to broaden their treatment offerings. As a result, medical institutions are investing in these advanced systems, boosting market growth and encouraging manufacturers to speed up product innovation while improving the reputation of healthcare facilities for providing state-of-the-art care.

Restraints in the Global Radiosurgery And Radiotherapy Robotics Market

The high initial investment required for advanced radiosurgery robots presents a significant obstacle in the Global Radiosurgery and Radiotherapy Robotics market. Healthcare providers face considerable costs associated with hardware, installation, and specialized training, which are often seen as financially daunting. Institutions with tight budgets must meticulously assess the cost-benefit ratios, frequently delaying purchases until reliable reimbursement options are confirmed. This financial hesitance contributes to sluggish market growth, particularly in areas with limited public funding. As a result, the substantial capital required inhibits the rapid adoption of new robotic systems within the clinical environment.

Market Trends of the Global Radiosurgery And Radiotherapy Robotics Market

The Global Radiosurgery and Radiotherapy Robotics market is increasingly characterized by the integration of artificial intelligence, revolutionizing treatment planning processes. Innovations in imaging analysis, automated contouring, and predictive dose optimization are streamlining clinical workflows, significantly reducing planning times while enhancing precision in targeting tumors. Clinicians are empowered by algorithm-driven insights, which facilitate personalized treatment approaches without straining resources. This evolution not only broadens access to advanced cancer therapies but also elevates patient satisfaction and clinical success rates. As healthcare institutions adopt these technologies, the market is poised for substantial growth, emphasizing efficiency and improved patient care in oncology.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Radiosurgery and Radiotherapy Robotics Market Size by Offering Component & CAGR (2026-2033)

• Market Overview
• Robotic Systems
  • Robotic Radiotherapy Systems
  • Robotic Radiosurgery Systems
• Software Solutions
• 3D Position Monitoring Cameras
• Technical Services

Global Radiosurgery and Radiotherapy Robotics Market Size by Underlying Technology & CAGR (2026-2033)

• Market Overview
• Linear Accelerators
• Stereotactic Radiation Systems
• Particle Therapy Systems

Global Radiosurgery and Radiotherapy Robotics Market Size by Clinical Application Focus & CAGR (2026-2033)

• Market Overview
• Prostate Cancer
• Brain Tumors
• Lung Cancer
• Spinal Lesions
• Liver Lesions
• Others

Global Radiosurgery and Radiotherapy Robotics Market Size by Healthcare End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Specialty Cancer Clinics
• Academic Research Institutions

Global Radiosurgery and Radiotherapy Robotics Market Size & CAGR (2026-2033)

• North America (Offering Component, Underlying Technology, Clinical Application Focus, Healthcare End User)
  • US
  • Canada
• Europe (Offering Component, Underlying Technology, Clinical Application Focus, Healthcare End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering Component, Underlying Technology, Clinical Application Focus, Healthcare End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering Component, Underlying Technology, Clinical Application Focus, Healthcare End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering Component, Underlying Technology, Clinical Application Focus, Healthcare End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Medical Technologies Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA Proton Therapy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mevion Medical Systems Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Heavy Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProTom International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optivus Proton Therapy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DosiSoft SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScandiDos AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vision RT Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Radiotherapy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LAP GmbH Laser Applikationen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linatech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Oncotherapy plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations